Bavarian Nordic may well upgrade again, says Sydbank analyst
The US government’s order of Bavarian Nordic’s monkeypox vaccine will not be the last, says Sydbank senior analyst Søren Løntoft Hansen.
by marketwire, translated by catherine brett
On Friday, June 10, Bavarian Nordic upgraded its financial guidance for 2022 for the third time in three weeks.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
